• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Non commercial use only - Italian Journal of Medicine
Non commercial use only - Italian Journal of Medicine

... as indirect drugs. Vitamin K antagonists act by reducing the synthesis of clotting factors so reducing the power of clotting ability.1 Heparins act through their link with antithrombin so inducing an increased and fast inhibition of activated clotting factors.2 The efficacy of these drugs has been s ...
Selective mutation in ATP-binding site reduces affinity of drug to the
Selective mutation in ATP-binding site reduces affinity of drug to the

... residues. Docking studies identified 14 residues which are critical for the interactions (Table S1) and these residues are also well conserved within the family (Fig. 1F). Then, we determined whether inhibitor interacting residues are common for other kinase inhibitors. PKCβ2 was used as a macromole ...
The Drugs - chem4520
The Drugs - chem4520

... microbial agent required to make several different 2-nitroimidazole based compounds • Very good yield • The best yields and shorter reaction times were obtain when DMSO was used as a solvent ...
Transformation of Peptides into Non-Peptides
Transformation of Peptides into Non-Peptides

... novel inhibitor structure in that the core portion of the inhibitor lacks nitrogen. At the time we began this work, no nonnitrogen-containing tight-binding inhibitors of pepsin were known, and we simplified 8 to produce a series of compounds designed to determine whether GrowMol had produced a reali ...
The importance of residence and recognition time of drug
The importance of residence and recognition time of drug

... is of crucial importance for its in vivo effect The slope in the dose response curves from the rat arterial thrombosis model is related with the k on ...
life.nthu.edu.tw
life.nthu.edu.tw

... • Summation and potentiation • effect of two drugs given at the same time may be – Additive 2+3 = 5 – Synergistic 2+3 = 8 – Potentiation 0+2 = 4 – e.g. in AIDS treatment, combining of AZT, 3TC and protease inhibitors ...
Chapter 12 Section F: Blood and Hemostasis
Chapter 12 Section F: Blood and Hemostasis

... factors as shown in Figure 12-76 and Table 12-13 on page 459. Rather, it is important to understand the general scheme of the clotting pathways and the roles of thrombin, fibrinogen, and vitamin K. How does blood clotting normally begin? At what point does the intrinsic pathway become involved? Coag ...
New oral anticoagulants
New oral anticoagulants

... Rivaroxaban does not routinely require monitoring of therapeutic response (unlike warfarin). However, if a patient has an episode of bleeding or requires an invasive procedure, measurement of an anticoagulant effect may be advantageous. A standard clotting screen has not been validated for assessing ...
An Overview of HIV Drugs
An Overview of HIV Drugs

... Closer Look: Zidovudine  1st approved drug for the treatment of AIDS  Phosphorylated by 3 cellular enzymes to form an active nucleotide triphosphate  Analogue of deoxythymidine where the 3’ hydroxyl is replaced by an azide group  The triphosphate is attached to the growing DNA chain, but cannot ...
Inhibitors of Protein Synthesis
Inhibitors of Protein Synthesis

... • Change in ribosome binding site – Plasmid encoded protein that binds to ribosome and blocks binding site (presumably without preventing tRNA binding itself) ...
Table 1 Cholesterol Med Chart
Table 1 Cholesterol Med Chart

... Avoid in females of childbearing age. If used, discontinue when pregnancy is contemplated. Well tolerated for mild hypercholesterolemia. Simvastatin is the most potent on a milligram basis. ...
PowerPoint Presentation - Anticoagulants and Thrombolytics
PowerPoint Presentation - Anticoagulants and Thrombolytics

...  Active in vitro and in vivo  Administration - parenteral- Do not inject IM only IV or deep s.c.  Half-life 1 - 5 hrs - monitor aPTT  Adverse effect - hemorrhage - antidote protamine sulphate ...
mr-afib
mr-afib

... • apixaban was associated with lower risk (hazard ratio [HR] 0.67, 95% CI 0.46–0.98, P=0.04) • dabigatran and rivaroxaban were associated with a similar risk (dabigatran: HR 0.98, 95% CI 0.76– ...
ppt
ppt

... Total binding measured in the presence of increasing concentrations of labeled ligand • Non-specific binding measured as above but in the presence of excess unlabeled (cold) ligand • Specific binding is the subtraction of the two ...
`drug`.
`drug`.

... The drug must fit into the Binding Site and shape complementarity is an important feature of a drug molecule. Competitive enzyme inhibitors often bear a resemblance to the substrate, as they bind to the same Active Site. This is also true for some receptor antagonists, but not all. The strength of a ...
Pharmacokinetic drug interaction
Pharmacokinetic drug interaction

... Ca salts; or Fe preparations) can significantly decrease the absorption of those drugs and in some cases lead to treatment failure. Even multivitamin preparations that contain lower concentrations of minerals should be avoided. Similar adverse effects on fluoroquinolone absorption were observed with ...
MICROBIOTIX, INC
MICROBIOTIX, INC

... bacterial adhesion, evasion of host immune response, nutrient acquisition and host cell invasion. Interference with the display of surface proteins on the bacterial cell membrane by inhibition of sortase A is an effective mechanistic approach to antibacterial therapy. Currently, no sortase inhibitor ...
Slide 1
Slide 1

... Factor Xa, thrombin and tissue factor contribute to tumor growth. Factor Xa promote tumor growth in 2 ways: Fibrin provide network for growth and block access of immune system. Recognition and binding to tumor cell to initiate cellular event. Heparin suppress small cell lung cancer and B16 melano ...
B. Drug-receptor interactions
B. Drug-receptor interactions

... Electronic dipole is formed when we have polarized bond. In the polarized bond one of the pole will be partially positive and the other partially ...
anemia: symptoms - Oregon Health & Science University
anemia: symptoms - Oregon Health & Science University

... General LMWH Plan • Change warfarin patients to LMWH • Continue full dose until platelets <50,000/uL • “Prophylactic” dose until platelet <20,000/uL – Enoxaparin 40mg/day – Several studies have shown this dose effective for treatment ...


... critical motif for activity was the tripeptide WVG, tryptophan and valine represents a hydrophobic component next to an amide functionality of glutamine. A number of small molecules have been synthesised as potential drug candidates based on this structure. A caprolactam was used in place of the glu ...
RIVAROXABAN: chemical structure
RIVAROXABAN: chemical structure

... Complicated synthesis with more than 50 steps ...
Local New Medicine Treatment Protocol Template
Local New Medicine Treatment Protocol Template

... haemorrhage. Appropriate symptomatic treatment could be used as needed, such as mechanical compression (e.g. for severe epistaxis), surgical haemostasis with bleeding control procedures, fluid replacement and haemodynamic support, blood products (packed red cells or fresh frozen plasma, depending on ...
DRUGS AFFECTING CLOT FORMATION
DRUGS AFFECTING CLOT FORMATION

... tract, metabolized in the liver, and excreted in urine and feces. Warfarin’s onset of action is about 3 days; its effects last for 4 to 5 days. Because of the time delay, warfarin is not the drug of choice in an acute situation, but it is convenient and useful for prolonged effects. ...
Advanced Medicinal Chemistry
Advanced Medicinal Chemistry

... P1 is the primary specificity site ...
< 1 ... 24 25 26 27 28 29 >

Discovery and development of direct Xa inhibitors

  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report